Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ENMS With Balance Feedback for Post-stroke Ankle-foot Rehabilitation

NCT: NCT04934787 · RECRUITING

NCT IDNCT04934787
StatusRECRUITING
Start Date2021-07-01
Completion2027-12-31
SponsorThe Hong Kong Polytechnic University (OTHER)
First posted
Last updated

Brief Summary

In this work, a novel hybrid ankle-foot robot is designed for gait rehabilitation after stroke, i.e., exoneuromusculoskeleton with balance sensing feedback (ENMS-BSF) by integrating the advantages of soft pneumatic muscle, functional electrical stimulation, exoskeleton and foot balance feedback in one system. With the assistance of the ENMS-BSF the foot drop and foot inversion could be corrected with improved muscle coordination in the paretic lower limb. The device is wearable and light-in-weight for unilateral application during walking. It is hypothesized that with the intervention of the ENMS-BSF the gait pattern of persons after stroke can be improved with long-term rehabilitative effects.

Frequently Asked Questions

What is ENMS With Balance Feedback for Post-stroke Ankle-foot Rehabilitation?

ENMS With Balance Feedback for Post-stroke Ankle-foot Rehabilitation is a clinical trial registered under NCT04934787. Current status: RECRUITING.

What is the status of NCT04934787?

The current status of NCT04934787 (ENMS With Balance Feedback for Post-stroke Ankle-foot Rehabilitation) is: RECRUITING.

When did ENMS With Balance Feedback for Post-stroke Ankle-foot Rehabilitation start?

ENMS With Balance Feedback for Post-stroke Ankle-foot Rehabilitation started on 2021-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.